SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Acquired by Jones Financial Companies Lllp

Jones Financial Companies Lllp increased its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 146.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 993 shares of the company’s stock after acquiring an additional 590 shares during the period. Jones Financial Companies Lllp’s holdings in SPDR S&P Pharmaceuticals ETF were worth $43,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of XPH. Stifel Financial Corp purchased a new position in SPDR S&P Pharmaceuticals ETF during the third quarter worth approximately $337,000. JPMorgan Chase & Co. lifted its position in SPDR S&P Pharmaceuticals ETF by 36.2% during the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after buying an additional 1,182 shares in the last quarter. Sigma Planning Corp purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $221,000. Arlington Financial Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $291,000. Finally, US Bancorp DE purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $96,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of SPDR S&P Pharmaceuticals ETF stock opened at $43.71 on Wednesday. The business’s 50 day moving average price is $44.34 and its 200 day moving average price is $44.75. The company has a market cap of $157.36 million, a price-to-earnings ratio of 15.01 and a beta of 0.72. SPDR S&P Pharmaceuticals ETF has a one year low of $38.88 and a one year high of $48.76.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.